AGEN Stock Analysis: Buy, Sell, or Hold?
AGEN - Agenus Inc.
$3.23
-0.36 (-9.92%)
▼
5d:
-1.07%
30d:
-32.67%
90d:
+5.74%
BUY
HIGH Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 11, 2026
0d
Smart Money Accumulation
AGEN is down 6.3% this week, but smart money is accumulating calls. Top strike: $5 2026-06-18 with 171 OI. Call ratio: 88% View Scanner →
Strength: 6.9/10
Get Alerted When AGEN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
3 traders called AGEN this week
75% bullish • 1 bearish
75% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: AGEN shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: AGEN shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: AGEN is currently trading at $3.23, which is considered oversold relative to its 30-day fair value range of $3.55 to $4.40. From a valuation perspective, the stock is trading at a discount (Forward PE: -1.6) compared to its historical average (5.1). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, AGEN is in a uptrend. The price is currently testing key support at $3.20. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 9.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.50 (+333.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, AGEN is in a uptrend. The price is currently testing key support at $3.20. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 9.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.50 (+333.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.55 -
$4.40
Company Quality Score
54/100
(HOLD)
Options IV Signal
32th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
77.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 32th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-9.9%)
- BULLISH: Trading 333.0% below Wall St target ($15.50)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Trading Range Analysis
30-Day Trading Range
$3.55 -
$4.40
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.46
(14.3%)
Support & Resistance Levels
Support Level
$3.20
Resistance Level
$4.27
Current Trend
Uptrend
Technical data as of
May 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.56
Wall Street Target
$15.50
(+333.0%)
Revenue Growth (YoY)
40.2%
Profit Margin
52.2%
PE vs Historical
-1.6 vs 5.1
CHEAP
Share & Embed Analysis
Last updated: May 18, 2026 1:10 PM ET
Data refreshes hourly during market hours. Next update: 2:10 PM
Data refreshes hourly during market hours. Next update: 2:10 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AGEN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$270 | 61 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 57 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$103 | 55 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$126 | 48 HOLD |
Advanced AGEN Option Strategies
Professional options setups generated by AI based on today's AGEN price and gamma walls.
